News about Global Pharma

CuraTeQ Biologics Secures Approval for Biosimilar Zefylti from UK's MHRA

Aurobindo Pharma announced that its subsidiary CuraTeQ Biologics has received UK MHRA approval for Zefylti, a filgrastim biosimilar for treating neutropenia, marking its second MHRA-approved biosimilar.
<br />

Global Pharma | 14/05/2025 | By Manvi |  546

Caplin Steriles Receives USFDA Approval for Haloperidol Decanoate Injection

Caplin Steriles Ltd., a subsidiary of Caplin Point Ltd., gets an entry into the US market with the final approval from Abbreviated New Drug Application (ANDA) for Haloperidol Decanoate Injection.

Global Pharma | 14/05/2025 | By Manvi |  459

Terumo Neuro Launches SOFIA 88, Expanding Stroke Portfolio with Large-Bore Catheter

The launch builds on the proven clinical performance and global legacy of the SOFIA™ Catheter line, which has supported more than 500,000 procedures across 170 countries over the past decade.

Global Pharma | 13/05/2025 | By Manvi |  318

Eargo Unveils Eargo 8, First OTC Hearing Aid from Newly Formed LXE Hearing

Eargo, Inc., an LXE Hearing company on a mission to improve the quality of life of people with hearing loss, announced the launch of Eargo 8, its most advanced self-fitting over-the-counter (OTC) hearing aid yet.

Global Pharma | 13/05/2025 | By Manvi |  762

Collegium Pharmaceutical Buy Back USD 25 million in shares

Collegium maintains impressive gross profit margins of 87.04 percent and has achieved revenue growth of 17.17 percent over the last twelve months. This growth is attributed to strong sales in the company’s pain management portfolio and the ADHD medication Jornay PM.

Global Pharma | 13/05/2025 | By Manvi |  235

Colorcon and ASHA Cellulose Partner for Ethyl Cellulose Polymer Distribution

Colorcon and ASHA Cellulose have partnered to support the development and manufacture of barrier membrane formulations for the pharmaceutical and nutraceutical industries.

Global Pharma | 12/05/2025 | By Manvi |  438

Cellarity Appoints Ted Myles as Chief Executive Officer

Cellarity and Flagship Pioneering have appointed veteran biopharma executive Ted Myles as Chief Executive Officer of Cellarity and CEO-Partner at Flagship, as the company prepares to enter clinical development with its lead AI-driven program.

Global Pharma | 12/05/2025 | By Manvi |  341

Mediso Completes First Phase of MRI Tech Transfer Agreement with SSI

Mediso announced the successful completion of the first phase of a strategic technology transfer agreement with Superconducting Systems Inc. (SSI), a fully owned subsidiary of IMRIS. This agreement marks a significant milestone in Mediso's long-term commitment to vertical integration and innovation in the field of MRI system development.

Global Pharma | 12/05/2025 | By Manvi |  322

FDA Approves Teal Wand, First At-Home Cervical Cancer Screening Device

Teal Health®, a women's health company on a mission to eliminate cervical cancer, announced the Food and Drug Administration's (FDA) approval of the Teal Wand™, the first and only at-home vaginal sample self-collection device for cervical cancer screening in the United States.

Global Pharma | 12/05/2025 | By Manvi |  289

US President to Announce Prescription Drug Price Cut by up to 80 Percent

The United States of America will grow and make huge profits after President Donald Trump signed the executive order lowering prescription drug and pharmaceutical prices.

Global Pharma | 12/05/2025 | By Manvi |  175